(NASDAQ:EVAX), COPENHAGEN, Denmark, January 7, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines, will present at the Biotech Showcase conference taking place from January 12-14, 2026, in San Francisco, California. CEO Helen Tayton-Martin will present Evaxion's 2026 company milestones and provide a company update on January […]

Rezolve Ai to Take Center Stage at NRF 2026 as Agentic Commerce Emerges as Retail's Next Growth Engine Live Demonstrations with Microsoft to Highlight Enterprise Adoption [as AI Agents Drive Revenue at Scale] GlobeNewswire January 07, 2026 LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in Agentic Commerce and AI-powered

(NASDAQ:SNSE), PARIS, Jan. 07, 2026 (GLOBE NEWSWIRE) — Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with autoimmune diseases and cancer, today announced the appointment of John Celebi, M.B.A., as chief executive officer. Mr. Celebi is a seasoned biotechnology executive

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240 GlobeNewswire January 07, 2026 IM1240 demonstrated improved safety in a toxicology study at doses up to 300-fold higher than a non-capped comparator IM1240's pharmacokinetic profile showed increased systemic exposure and a prolonged circulating half-life enabled by its human serum

BitFuFu Announces December 2025 Bitcoin Production and Operational Updates GlobeNewswire January 07, 2026 SINGAPORE, Jan. 07, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for December 2025. “In 2025 we mined 3,662 BTC, reduced

Picard Medical Announces Conference Participation During J.P. Morgan Healthcare Conference Week GlobeNewswire January 07, 2026 TUCSON, Ariz., Jan. 07, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world's first total artificial heart approved by both the U.S. Food and Drug

Mixie Technologies, Inc. (PHCG), formerly Pure Harvest Corporate Group, Secures Minority Ownership Stake in HoloTwin LLC Acquisition solidifies Mixie's expansion into AI-driven digital twin solutions and supports partner-centric scaling across infrastructure, energy, security, and wiring ecosystems GlobeNewswire January 07, 2026 DENVER, Jan. 07, 2026 (GLOBE NEWSWIRE) — Mixie Technologies, Inc. (OTC: PHCG), formerly known as

Duos Edge AI Deploys Edge Data Center in Abilene, Texas New Region 14 Education Service Center Partnership Advances AI Infrastructure for Education and Community Growth in West Texas GlobeNewswire January 07, 2026 JACKSONVILLE, Fla., and ABILENE, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) — Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its

Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today

LM Funding America Announces December 2025 Production and Operational Update GlobeNewswire January 07, 2026 – Bitcoin treasury as of December 31, 2025 valued at $31.4 million or $1.46 per share1 TAMPA, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company,